These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15718486)
1. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies. Warren DJ; Bjerner J; Paus E; Børmer OP; Nustad K Clin Chem; 2005 May; 51(5):830-8. PubMed ID: 15718486 [TBL] [Abstract][Full Text] [Related]
2. Testing and validating a homogeneous immunometric assay for interference. Bjerner J; Olsen KH; Børmer OP; Nustad K Clin Chem Lab Med; 2004 Feb; 42(2):208-14. PubMed ID: 15061363 [TBL] [Abstract][Full Text] [Related]
3. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. Kuroki M; Matsumoto Y; Arakawa F; Haruno M; Murakami M; Kuwahara M; Ozaki H; Senba T; Matsuoka Y J Immunol Methods; 1995 Mar; 180(1):81-91. PubMed ID: 7897248 [TBL] [Abstract][Full Text] [Related]
4. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera. Bolstad N; Warren DJ; Bjerner J; Kravdal G; Schwettmann L; Olsen KH; Rustad P; Nustad K Clin Chem Lab Med; 2011 Sep; 49(12):2001-6. PubMed ID: 21899496 [TBL] [Abstract][Full Text] [Related]
5. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique. Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of alpha-fetoprotein and carcinoembryonic antigen in human serum by time-resolved fluoroimmunoassay. Matsumoto K; Yuan J; Wang G; Kimura H Anal Biochem; 1999 Dec; 276(1):81-7. PubMed ID: 10585747 [TBL] [Abstract][Full Text] [Related]
8. Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones. Rodenburg CM; Mernaugh R; Bilbao G; Khazaeli MB Hybridoma; 1998 Feb; 17(1):1-8. PubMed ID: 9523232 [TBL] [Abstract][Full Text] [Related]
9. Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments. Eriksson S; Vehniäinen M; Jansén T; Meretoja V; Saviranta P; Pettersson K; Lövgren T Clin Chem; 2000 May; 46(5):658-66. PubMed ID: 10794748 [TBL] [Abstract][Full Text] [Related]
10. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently. Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782 [TBL] [Abstract][Full Text] [Related]
11. Heterophilic antibody interference in immunometric assays. Bolstad N; Warren DJ; Nustad K Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):647-61. PubMed ID: 24094636 [TBL] [Abstract][Full Text] [Related]
12. Eliminating heterophilic antibody interference for ferritin detection using Olympus F(ab')2 based reagent. Grouzmann E; Dayer N; Bain C; Neville CM; McCusker MD; Wang RY Clin Lab; 2008; 54(9-10):355-7. PubMed ID: 19097493 [TBL] [Abstract][Full Text] [Related]
13. Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab')2 conjugate and polyclonal mouse IgG. Vaidya HC; Beatty BG Clin Chem; 1992 Sep; 38(9):1737-42. PubMed ID: 1526006 [TBL] [Abstract][Full Text] [Related]
14. Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody. Marshall D; Pedley RB; Melton RG; Boden JA; Boden R; Begent RH Br J Cancer; 1995 Jan; 71(1):18-24. PubMed ID: 7529526 [TBL] [Abstract][Full Text] [Related]
15. Elimination of falsely reactive results in a commercially-available West Nile virus IgM capture enzyme-linked immunosorbent assay by heterophilic antibody blocking reagents. Prince HE; Lapé-Nixon M; Givens TS; Bradshaw T; Nowicki MJ J Immunol Methods; 2017 May; 444():24-28. PubMed ID: 28216236 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies. Welfringer F; d'Athis P; Scherrmann JM; Hervé F J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797 [TBL] [Abstract][Full Text] [Related]
18. Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Cloutier SM; Couty S; Terskikh A; Marguerat L; Crivelli V; Pugnières M; Mani JC; Leisinger HJ; Mach JP; Deperthes D Mol Immunol; 2000 Dec; 37(17):1067-77. PubMed ID: 11399324 [TBL] [Abstract][Full Text] [Related]
19. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody. Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542 [TBL] [Abstract][Full Text] [Related]
20. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]